Cargando…

The role of m(6)A modification in physiology and disease

Similar to DNA epigenetic modifications, multiple reversible chemical modifications on RNAs have been uncovered in a new layer of epigenetic modification. N6-methyladenosine (m(6)A), a modification that occurs in ~30% transcripts, is dynamically regulated by writer complex (methylase) and eraser (RN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chuan, Hu, Yiyang, Zhou, Bo, Bao, Yulu, Li, Zhibin, Gong, Chunli, Yang, Huan, Wang, Sumin, Xiao, Yufeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649148/ https://www.ncbi.nlm.nih.gov/pubmed/33162550 http://dx.doi.org/10.1038/s41419-020-03143-z

Ejemplares similares

Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification
por: Hu, Yiyang, et al.
Publicado: (2022)

hTERT Promotes CRC Proliferation and Migration by Recruiting YBX1 to Increase NRF2 Expression
por: Gong, Chunli, et al.
Publicado: (2021)

Function of Non-coding RNA in Helicobacter pylori-Infected Gastric Cancer
por: Wang, Chao, et al.
Publicado: (2021)

Effects of Environmental and Pathological Hypoxia on Male Fertility
por: Li, Zhibin, et al.
Publicado: (2021)

m6A modification in RNA: biogenesis, functions and roles in gliomas
por: Zhang, Yuhao, et al.
Publicado: (2020)

Emerging role of m6A methylation modification in ovarian cancer
por: Chang, Lin-Lin, et al.
Publicado: (2021)

Roles of m(6)A modification in oral cancer (Review)
por: Liu, Huimin, et al.
Publicado: (2022)

Emerging roles of N6-methyladenosine (m(6)A) modification in breast cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

The Role of m(6)A Modification and m(6)A Regulators in Esophageal Cancer
por: Li, Yuekao, et al.
Publicado: (2022)

A new perspective on Alzheimer’s disease: m6A modification
por: Xia, Lei, et al.
Publicado: (2023)

The role of m6A modification in the biological functions and diseases
por: Jiang, Xiulin, et al.
Publicado: (2021)

Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis
por: Zhai, Ganggang, et al.
Publicado: (2022)

Roles of N(6)‐methyladenosine (m(6)A) RNA modifications in urological cancers
por: Wang, Xiao, et al.
Publicado: (2020)

Identification of KRBA1 as a Potential Prognostic Biomarker Associated with Immune Infiltration and m6A Modification in Hepatocellular Carcinoma
por: Liu, Yue, et al.
Publicado: (2022)

Reshaping the role of m6A modification in cancer transcriptome: a review
por: Yang, Guanqun, et al.
Publicado: (2020)

Roles of RNA m6A modification in nonalcoholic fatty liver disease
por: Tan, Jian, et al.
Publicado: (2023)

The Role of m6A Epigenetic Modification in the Treatment of Colorectal Cancer Immune Checkpoint Inhibitors
por: Tong, Huan, et al.
Publicado: (2022)

The role of RNA m(5)C modification in cancer metastasis
por: Zhang, Qiaofeng, et al.
Publicado: (2021)

Roles of N(6)-methyladenosine (m(6)A) modifications in gynecologic cancers: mechanisms and therapeutic targeting
por: Chen, Jiahua, et al.
Publicado: (2022)

N(6)-methyladenosine (m(6)A) RNA modification in gastrointestinal tract cancers: roles, mechanisms, and applications
por: Hu, Bin-bin, et al.
Publicado: (2019)

The Mechanism and Role of N(6)-Methyladenosine (m(6)A) Modification in Atherosclerosis and Atherosclerotic Diseases
por: Tan, Quandan, et al.
Publicado: (2022)

The role of m(6)A and m(6)Am RNA modifications in the pathogenesis of diabetes mellitus
por: Benak, Daniel, et al.
Publicado: (2023)

The crucial roles of N(6)-methyladenosine (m(6)A) modification in the carcinogenesis and progression of colorectal cancer
por: Fang, Zhihao, et al.
Publicado: (2021)

Role of Hakai in m(6)A modification pathway in Drosophila
por: Wang, Yanhua, et al.
Publicado: (2021)

The emerging roles of m(6)A modification in liver carcinogenesis
por: Pan, Xue-yin, et al.
Publicado: (2021)

The Emerging Role of m6A Modification in Endocrine Cancer
por: Ji, Xiaoyu, et al.
Publicado: (2023)

RNA modification m(6)Am: the role in cardiac biology
por: Benak, Daniel, et al.
Publicado: (2023)

Regulatory Role of N6-methyladenosine (m(6)A) Modification in Osteosarcoma
por: Zhang, Yujie, et al.
Publicado: (2021)

The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma
por: He, Cheng, et al.
Publicado: (2023)

ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m(6)A modification, and drug susceptibility
por: Ding, Yongqi, et al.
Publicado: (2023)

The current landscape of m6A modification in urological cancers
por: Zeng, Yaohui, et al.
Publicado: (2023)

Biological and pharmacological roles of m(6)A modifications in cancer drug resistance
por: Liu, Zaoqu, et al.
Publicado: (2022)

Comprehensive Transcriptomic Profiling of m6A Modification in Age-Related Hearing Loss
por: Feng, Menglong, et al.
Publicado: (2023)

Detection of m(6)A RNA modifications at single-nucleotide resolution using m(6)A-selective allyl chemical labeling and sequencing
por: Peng, Yong, et al.
Publicado: (2022)

The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs
por: Zhang, Lele, et al.
Publicado: (2020)

The Role of N(6)-Methyladenosine (m(6)A) Methylation Modifications in Hematological Malignancies
por: Zhao, Yan, et al.
Publicado: (2022)

CSTF2 mediated mRNA N(6)-methyladenosine modification drives pancreatic ductal adenocarcinoma m(6)A subtypes
por: Zheng, Yanfen, et al.
Publicado: (2023)

The detection and functions of RNA modification m(6)A based on m(6)A writers and erasers
por: Zhang, Wei, et al.
Publicado: (2021)

The Role of m6A Ribonucleic Acid Modification in the Occurrence of Atherosclerosis
por: Fu, Jie, et al.
Publicado: (2021)

Roles and therapeutic implications of m6A modification in cancer immunotherapy
por: Pan, Juan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_51s7b96012gtve4mp6ro00bgnn